QCM Cayman, Ltd. - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 172 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
QCM Cayman, Ltd. ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$87,000
+6.1%
13,597
-3.1%
0.06%
+118.5%
Q3 2015$82,000
-60.8%
14,025
-63.7%
0.03%
-44.9%
Q3 2014$209,000
+145.9%
38,614
+190.1%
0.05%
+19.5%
Q2 2014$85,000
-67.1%
13,309
-58.3%
0.04%
-29.3%
Q1 2014$258,00031,9530.06%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,331,100$23,281,0008.28%
DAFNA Capital Management LLC 191,215$3,344,0004.89%
Redmile Group, LLC 1,277,109$22,337,0003.94%
BB BIOTECH AG 3,115,371$54,488,0003.92%
SECTORAL ASSET MANAGEMENT INC 5,292,682$92,569,0002.74%
IRONWOOD INVESTMENT MANAGEMENT LLC 565,956$9,899,0001.76%
OAK RIDGE INVESTMENTS LLC 2,645,781$46,275,0001.45%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,104$22,127,0001.04%
Tekla Capital Management LLC 412,965$7,223,0000.98%
Private Capital Advisors, Inc. 127,600$2,232,0000.83%
View complete list of ARIAD PHARMACEUTICALS INC shareholders